Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Adaptive Biotechnologies Announces New Data Highlighting the Actionability of clonoSEQ in Blood Cancer Treatment Decisions at ASH Annual Meeting

New data highlights clonoSEQ's effectiveness in guiding treatment decisions for patients with various blood cancers.Quiver AI SummaryAdaptive Biotechnologies Corporation has announced new data highlighting...

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies' clonoSEQ Test Featured in Record Number of Abstracts at 66th Annual ASH Meeting

Adaptive Biotechnologies' clonoSEQ test for MRD assessment will feature prominently at the ASH Annual Meeting 2024.Quiver AI SummaryAdaptive Biotechnologies Corporation announced that its clonoSEQ® test...

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies: Q3 Earnings Snapshot

Adaptive Biotechnologies: Q3 Earnings Snapshot

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

ADPT : 6.39 (+6.50%)
Adaptive Biotechnologies: Q2 Earnings Snapshot

Adaptive Biotechnologies: Q2 Earnings Snapshot

ADPT : 6.39 (+6.50%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular growth investor keeps adding to some of her favorite falling stocks.

SHOP : 108.95 (+1.76%)
NTLA : 12.18 (+0.83%)
ADPT : 6.39 (+6.50%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar